We should aim to achieve complete elimination of hepatitis C
Clinical Pharmacist
Clinical Pharmacist
26 SEP 2016
Chair of the British Viral Hepatitis Group and Consultant in Infectious Diseases, North Manchester General Hospital
I read the letters from Charles Gore (Clinical Pharmacist 2016;8:232) and Anja St. Clair Jones (Clinical Pharmacist 2016;8:264) on the therapies and new services for hepatitis C with interest. The points made are valid and important.
The key issues highlighted by Gore were related to the fact that there are real restrictions placed on accessing the newer therapies for this infection that have not been imposed in other disease areas, with other medicines, in other patients. Resources are limited; however, denying individuals timely access to National Institute for Health and Care Excellence-approved, evidence-based, cost-effective therapies is, indeed, exceptional.
Continue reading: We should aim to achieve complete elimination of hepatitis C
No comments:
Post a Comment